Montefiore Einstein Division of Hepatology NYC
@MonteNYCliver
Followers
312
Following
736
Media
8
Statuses
219
Official account for Montefiore Einstein Division of Hepatology @MontefioreNYC @EinsteinMed @EinsteinDeptMed #transplant #peds no medical advice/own opinions
Bronx, NY
Joined June 2022
Baveno VIII is approaching: March 27-28 next year 2026 ▶️ Register https://t.co/CAKjVtCkbK ▶️ 15-DEC-2025 Early🐦 ▶️ 15-JAN-2026 Abstracts📩 @EASLnews @AASLDtweets @APASLnews @INASL_Liver @BavenoCoop
0
16
48
This is the most important #Liver #Cirrhosis conference in the next 5 Years : ⏩⏩ #BavenoVIII @BavenoCoop ⏪⏪ #PortalHypertension Guidelines #CSPH Everything U Need #EtiologicCure #Recompensation #SteatoticLiverDisease #ArLD #MASH
#NITs #LiverStiffness #SpleenStiffness #TIPS
0
19
69
🚨 Join us for the VALDIG PSVD Meeting – a 2-day event dedicated to PSVD! 🗓️ Dec 4–5, 2025 📍 CNAM, Paris 🇫🇷 💳 Onsite €150 (payment after reg.) | Online free 👉Organized by EURO-VALDIG NET & FILFOIE Register here ➡️ https://t.co/i4YgLSfbx8 Program 👇
0
5
11
MetALD associated with a higher risk of liver-related events, HCC, and extrahepatic cancers than MASLD, whereas all-cause mortality, extrahepatic cancer-related mortality, and cardiovascular events seem similar between the two conditions. https://t.co/PCdUyXbnub
2
6
21
The passing of Prof. Jaume Bosch (1947–2025) has generated, and continues to generate, heartfelt tributes Here you can read some of them: Scientific societies 🇪🇺EASL: https://t.co/v4Oz8jwAKF 🇪🇸AEEH: https://t.co/bW7fW0EzPB 🇨🇭SASL: https://t.co/gRSTJ3QWUN
3
9
56
Original Article Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death Vutien et al. #LiverX
https://t.co/ho0cLXA0eY
3
17
48
What is the 1-year survival rate after ICU admission for patients with cirrhosis? https://t.co/gZ8WMe6fZD
@HepCommJournal
journals.lww.com
, between 2007 and 2018 reported to the Australian and New Zealand Intensive Care Society Adult Patient Database were included. Poisson regression and Cox regression were used to explore factors...
0
7
13
Great paper recently published in @AGA_CGH led by @lindsayykingmd & @YucaSpice - a @AST_LICOP collaboration! Guidance for Timely Referral to Liver #Transplantation
https://t.co/qg1qiXeQrW
#livertransplantation #livertransplant
1
33
72
I’m going to #TLM25 in Washington, D.C.! Who’s joining me (and 9000+ hepatology professionals around the world) in moving the field forward? #LiverX #LiverTwitter
@VCU_Liver @AASLDtweets @AASLDPresident @AASLDFoundation
5
14
65
@BavenoCoop @EASLnews @AASLDtweets At any given #HVPG spleen stiffness #SSM was higher in 🍔#MASLD than in 🍷#ALD cirrhosis Suggesting a ⏮️PREsinusoidal #PortaHypertension component in #MASLD 📕@LiverInt study by our #Liver team @MedUni_Wien 🔗 https://t.co/XUZlFtK3lI
0
7
17
This is THE place to learn about applying to GI as a Hepato-curious resident. From considering fast-track vs. traditional 4th year Hepatology Fellowships to considerations for IMG applicants, this webinar will have it all! A do not miss!
⭐️ Step into your future in GI & Hepatology ⭐️ Applying to GI this cycle and interested in Hepatology? Join us for a webinar with fellows & program directors sharing practical insights on preparing for fellowship 🎯 Register here: https://t.co/gHYzX99V4s
@AASLDtweets
1
8
31
⭐️ Step into your future in GI & Hepatology ⭐️ Applying to GI this cycle and interested in Hepatology? Join us for a webinar with fellows & program directors sharing practical insights on preparing for fellowship 🎯 Register here: https://t.co/gHYzX99V4s
@AASLDtweets
1
14
26
We’re proposing a Clinical Informatics & Digital Health SIG to bring together members interested in EHR optimization, AI, clinical decision support, data science, mentorship & more. 👉 If the SIG is approved, would you join? DM me for details! @AASLDtweets @LiverFellow
0
11
29
📣 Announcing our 2025 #AASLDFoundation #EmergingLiverScholars 👏@OmarAlTaani @AHNIMres 👏@anouti_ahmad @UTSWMedCenter 👏Michael L. Attanasi North Shore University Hospital /LIJ Medical Center 👏@kia_bashiri @IMMWHC View the full list: https://t.co/spYSpZhaBl
3
15
70
Early #TIPSS for refractory ascites? > Check MELD, Na, and ascites grade 🌟New evidence from @balcar_lorenz & @salvatore_piano now in @JHEP_Reports If you deal with #cirrhosis, this is worth a look: 👉 https://t.co/kpEf3wLZHt
#liverX #livertwitter @EASLnews @BavenoCoop
0
25
63
Original Article Health IT interventions reduce avoidable readmissions in cirrhosis: The HEROIC randomized controlled trial Shaw et al. #LiverX
https://t.co/Wq36UHZNwO
0
3
5
Summer is the perfect time for exam prep! Beat the heat and study indoors with the Transplant Hepatology Board Review Course available now on-demand via LiverLearning®. https://t.co/kEwzyjRnAj
0
1
2
📢@AST_info Medical Directors Forum 2025 is your place to connect & learn 🗓️Aug 1–2 @cityofsanfran before @WTCMeeting 👩⚕️Medical director OR representative 🎟️Register for #WTC2025 is not required 🤝Organ-based breakout sessions 🔗 https://t.co/7rOGNCBCtY
#LiverTwitter #NephTwitter
0
6
11
With deep sadness, we share the passing of Dr. Jaime Bosch — a visionary researcher, passionate physician, and cherished friend. Widely regarded as the father of portal hypertension, the Liver Unit of Barcelona will always be indebted to his immense legacy.
40
48
223
Drs. @LorenzBALCAR of @MedUni_Wien & @martatonon935 identify a #cirrhosis population with #ascites at particular risk for short-term #PortalHypertension complications @JHEP_Reports
https://t.co/jz1qXNhtTs Ascites #Grade3 + 🚨MELD ≥12 or 🚨Na ≤135 ➡️ good candidates for #TIPS
0
22
38